Scout | PAR-25-442: Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

nofo PAR-25-442

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for exploratory and early-stage projects that focus on undruggable target classes within intractable human disease. Applicants will identify a human disease relevant undruggable target class and develop a method …

Funding Source

Agency: National Institutes of Health

Awards & funding

Total Funding: $1M

Eligibility

Native American tribal organizations (other than Federally recognized tribal governments)

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

Public and State controlled institutions of higher education

Small businesses

State governments

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving …

Supporting links

Full announcement

Documents

PAR-25-442 Full Announcement Text

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers